Skip to main content
Caplight Logo









CERV

CERV

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://cervmonitor.com

Last Round

Grant

Nov 20, 2024

Total Funding Raised

$3,000

Company Overview

CERV operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Grant round in November 2024.

CERV is a medical technology company that develops noninvasive, AI-powered devices for continuous cervical dilation monitoring during labor.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CERV Comparables

Compare CERV with similar companies based on industry and business-model similarity.

CERV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lidavex Inc.
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CERV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Sandy Montgomery

Co-Founder & CTO

Founding Team

Elizabeth Buzbee

Co-Founder, CEO

Founding Team

Annika Avula

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

CERV Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 55% MoM.

  • Nov 20, 2024

    $3K grant received from Skandalaris Center.

Book a demo to see all signals

For institutional investors. Book with your work email.

CERV Filings

Explore SEC and related filing metadata, where available.

CERV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CERV's valuation, stock price, and market status.

Is CERV a public or private company?

CERV is a private company.

What is the current stock price of CERV?

CERV is a private company, so its shares have no public market price. Caplight tracks CERV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CERV worth (valuation)?

Valuation information for CERV is not publicly available.

Can I buy CERV stock?

CERV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CERV's last funding round?

CERV's most recent funding round was Grant on November 20, 2024.

Who are the main investors in CERV?

Key investors in CERV include Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship.

Will CERV IPO soon?

No public IPO plans have been announced for CERV.

How can I track CERV secondary market activity?

Caplight tracks bids, offers, and trades in CERV's shares on secondary markets.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range3
Year Founded2024
Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?